/Companies

Liquet Medical

Glen Allen, US · Founded 2021 · Delaware corporation · 4 employees on LinkedIn · 1 known investors

Find your way into Liquet Medical

181 people in our graph can introduce you to the Liquet Medical team.

Sign up to see every warm intro you have to Liquet Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Liquet Medical team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Liquet Medical develops localized drug delivery technology for treating vascular disease. The company focuses on medical devices aimed at improving patient outcomes in vascular care.

Founders & leadership

Liquet Medical was founded in 2021 by John Schindler and Derek Hall.

JSJohn Schindler
John SchindlerCEO, Co-Founder, Board MemberCo-founder and CEO of Liquet Medical, which develops localized drug delivery technology for treating vascular disease. Schindler has focused on product and market development, business development, and sales training and management.
DHDerek Hall
Derek HallCOO, Co-Founder, Board MemberDerek Hall is Co-Founder and COO of Liquet Medical, which develops localized drug delivery technology for vascular disease. He has experience in medical device design and development, clinical sales leadership, and holds a Master's degree in Biomedical Engineering.
PH
Paul H. SartoriNamed on SEC filing
GC
Gary C. CupitNamed on SEC filing
KS
Koren SchindlerNamed on SEC filing

Board

GN
Gabriele NiederauerBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$3.3M disclosed across 6 rounds · 2021–2026

▶$75KraisedMar 2026 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul SartoriDirector
  • Derek HallExecutive Officer, Director
  • Mary ByronDirector
  • Gabriele NiederauerDirector
  • John SchindlerExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$75K
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMay 2025 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gabriele NiederauerDirector
  • Derek R. HallExecutive Officer, Director, Promoter
  • John J. SchindlerExecutive Officer, Director, Promoter
  • Paul H. SartoriDirector, Promoter
Offering amount
$1.5M
Amount sold
$1.1M
Minimum investment
$25K
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$615KraisedMay 2025 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul H. SartoriDirector, Promoter
  • Gabriele NiederauerDirector
  • John J. SchindlerExecutive Officer, Director, Promoter
  • Derek R. HallExecutive Officer, Director, Promoter
Offering amount
$800K
Amount sold
$615K
Minimum investment
$10K
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$405KraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul H. SartoriExecutive Officer, Director, Promoter
  • Derek R. HallExecutive Officer, Director, Promoter
  • John J. SchindlerExecutive Officer, Director, Promoter
  • Gary C. CupitDirector, Promoter
  • Koren SchindlerExecutive Officer, Promoter
Offering amount
$1M
Amount sold
$405K
First sale
Apr 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$605KraisedJun 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Derek HallExecutive Officer, Director, Promoter
  • Koren SchindlerExecutive Officer, Promoter
  • Paul SatoriExecutive Officer, Director, Promoter
  • Gary CupitDirector, Promoter
  • John SchindlerExecutive Officer, Director, Promoter
Offering amount
$1.4M
Amount sold
$605K
Minimum investment
$25K
First sale
May 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$550KraisedOct 2021 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John SchindlerExecutive Officer, Director, Promoter
  • Koren SchindlerExecutive Officer, Promoter
  • Gary CupitDirector, Promoter
  • Derek HallExecutive Officer, Director, Promoter
  • Paul SartoriDirector, Promoter
Offering amount
$2M
Amount sold
$550K
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Liquet Medical.

Frequently asked questions

What does Liquet Medical do?
Liquet Medical develops localized drug delivery technology for treating vascular disease. The company focuses on medical devices aimed at improving patient outcomes in vascular care.
Who founded Liquet Medical?
Liquet Medical was founded by John Schindler, Derek Hall in 2021.
Who are Liquet Medical's investors?
Liquet Medical's investors include Lighthouse Network Ventures Llc.
How much funding has Liquet Medical raised?
Liquet Medical has disclosed $3.3M raised across 6 rounds.
Where is Liquet Medical headquartered?
Liquet Medical is headquartered in Glen Allen, US.